| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 |
HALCYGEN PHARMACEUTICALS LIMITED (HGN)
Stock Code: HGN
Listing Date: 2007-06-29 00:00:00
Website: http://www.halcygen.com/
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
The testing and improvement of generic drugs
Address:
470 Collins Street, Level 10
MELBOURNE
VIC 3000
Phone: (03) 8614 7777
Fax: (03) 9614 7022
Executives & Directors
Dr Roger Aston, Chairman, CEO
Mr Criag Bottomley, Executive Director, Chief Op. Officer
The Hon Ron Best, Non Exec. Director
Mr Bruce Mathieson, Non Exec. Director
Mr Ian Scholes, Non Exec. Director
Mr Aaron Finlay, CFO
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
HGN - Submission of IND Application to US FDA - Dr Roger Aston, CEO
|
|
Wed, 14 May 2008 05:30PM |
| Annual General Meeting | Fri, 21 Nov 2008 11:00AM |
|
| Full Year Results | Mon, 20 Oct 2008 | |
| Interim Results | Fri, 29 Feb 2008 | |
| Annual General Meeting | Tue, 20 Nov 2007 10:00AM |
|
| Full Year Results | Fri, 31 Aug 2007 | |
| Full Year Results | Thu, 28 Jun 2007 |
HALCYGEN PHARMACEUTICALS LIMITED (HGN)
| Annual General Meeting Presentation | Fri, 21 Nov 2008 |
| Results of Meeting | Fri, 21 Nov 2008 |
| Second Study Recruitment and Dosing Completed | Fri, 21 Nov 2008 |
| Appendix 4C - quarterly | Mon, 27 Oct 2008 |
| Notice of Annual General Meeting | Mon, 20 Oct 2008 |
| Annual Report to shareholders | Mon, 20 Oct 2008 |
| Change of Director`s Interest Notice | Fri, 17 Oct 2008 |
| Change of Director`s Interest Notice | Wed, 15 Oct 2008 |
| Change of Director`s Interest Notice | Tue, 14 Oct 2008 |
| First successful pivotal trial complete | Tue, 7 Oct 2008 |
| Full Year Statutory Accounts | Tue, 30 Sep 2008 |
| Preliminary Final Report | Fri, 29 Aug 2008 |
| Appendix 4C - quarterly | Thu, 31 Jul 2008 |
| Recruitment and dosing for first PK study in US complete | Thu, 17 Jul 2008 |
| BioMelbourne Network Presentation | Thu, 19 Jun 2008 |
| FDA allows HalcyGen`s IND application | Tue, 17 Jun 2008 |
| Shares to be released from escrow | Fri, 13 Jun 2008 |
| New Potential Application for SUBA-Intraconazole in Oncology | Wed, 11 Jun 2008 |
| HalcyGen Files IND with FDA | Wed, 14 May 2008 |
| Appendix 4C - quarterly | Tue, 29 Apr 2008 |
| Commercial Scale Manufacture for SUBA-Itraconazole Trial | Fri, 14 Mar 2008 |
| Becoming a substantial holder and Appendix 3Y Notice | Wed, 12 Mar 2008 |
| Half Year Accounts | Fri, 29 Feb 2008 |
| Change of Director`s Interest Notice | Wed, 20 Feb 2008 |
| Change of Director`s Interest Notice | Fri, 15 Feb 2008 |
| Change of Director`s Interest Notice | Tue, 12 Feb 2008 |
| Appendix 4C - quarterly | Thu, 31 Jan 2008 |
| Shares to be released from escrow | Thu, 31 Jan 2008 |
| Change of Director`s Interest Notice | Wed, 19 Dec 2007 |
| Change of Director`s Interest Notice | Fri, 14 Dec 2007 |
| Change of Director`s Interest Notice | Wed, 12 Dec 2007 |
| Change of Director`s Interest Notice | Tue, 4 Dec 2007 |
| Appendix 3B | Fri, 30 Nov 2007 |
| FDA Provides Guidance on Registration Study | Thu, 29 Nov 2007 |
| Results of Meeting and Company Presentation | Tue, 20 Nov 2007 |
| Appendix 4C - quarterly | Mon, 29 Oct 2007 |
| Notice of Annual General Meeting/Proxy Form | Fri, 19 Oct 2007 |
| Annual Report to shareholders | Fri, 19 Oct 2007 |
| Director Appointment | Wed, 17 Oct 2007 |
| Full Year Statutory Accounts | Fri, 28 Sep 2007 |
| Change of Director`s Interest Notice | Thu, 13 Sep 2007 |
| Successful Second Clinical Study for SUBA-Itraconazole | Tue, 11 Sep 2007 |
| Shares to be Released from Escrow | Wed, 5 Sep 2007 |
| Preliminary Final Report | Fri, 31 Aug 2007 |
| Company Presentation | Thu, 23 Aug 2007 |
| HalcyGen begins second study of anti-fungal drug | Tue, 7 Aug 2007 |
| Anti-Fungal Drug Passes Clincial Test | Thu, 5 Jul 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.